Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Cell Prolif ; 53(10): e12903, 2020 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-32926483

RESUMEN

OBJECTIVE: Dysregulation of the cell cycle is associated with the progression of malignant cancer, but its precise functional contribution is unknown. MATERIALS AND METHODS: The expression of EIF1AX in breast cancer tissues was detected by qRT-PCR and immunohistochemistry staining. Colony formation and tumour xenograft assays were used to examine the tumorigenesis-associated function of EIF1AX in vitro and in vivo. RNA-Seq analysis was used to select the downstream target genes of EIF1AX. Flow cytometry, ChIP and luciferase assays were used to investigate the molecular mechanisms by which EIF1AX regulates p21 in breast cancer cells. RESULTS: EIF1AX promoted breast cancer cell proliferation by promoting the G1/S cell cycle transition. A mechanistic investigation showed that EIF1AX inhibited the expression of p21, which is an essential cell cycle regulator. We identified that the transcriptional regulation of p21 by EIF1AX was p53-independent. Clinically, EIF1AX levels were significantly elevated in breast cancer tissues, and the high level of EIF1AX was associated with lower survival rates in breast cancer patients. CONCLUSIONS: Our results imply that EIF1AX may play a key role in the incidence and promotion of breast cancer and may, thus, serve as a valuable target for breast cancer therapy.


Asunto(s)
Neoplasias de la Mama/patología , Proliferación Celular , Inhibidor p21 de las Quinasas Dependientes de la Ciclina/metabolismo , Factor 1 Eucariótico de Iniciación/metabolismo , Animales , Neoplasias de la Mama/metabolismo , Línea Celular Tumoral , Inhibidor p21 de las Quinasas Dependientes de la Ciclina/genética , Factor 1 Eucariótico de Iniciación/antagonistas & inhibidores , Factor 1 Eucariótico de Iniciación/genética , Femenino , Fase G1 , Humanos , Ratones , Ratones Desnudos , Interferencia de ARN , ARN Interferente Pequeño/metabolismo , Fase S , Activación Transcripcional , Proteína p53 Supresora de Tumor/metabolismo , Regulación hacia Arriba , Ensayos Antitumor por Modelo de Xenoinjerto
3.
Elife ; 2: e00498, 2013 May 28.
Artículo en Inglés | MEDLINE | ID: mdl-23741617

RESUMEN

Phosphorylation of the α-subunit of initiation factor 2 (eIF2) controls protein synthesis by a conserved mechanism. In metazoa, distinct stress conditions activate different eIF2α kinases (PERK, PKR, GCN2, and HRI) that converge on phosphorylating a unique serine in eIF2α. This collection of signaling pathways is termed the 'integrated stress response' (ISR). eIF2α phosphorylation diminishes protein synthesis, while allowing preferential translation of some mRNAs. Starting with a cell-based screen for inhibitors of PERK signaling, we identified a small molecule, named ISRIB, that potently (IC50 = 5 nM) reverses the effects of eIF2α phosphorylation. ISRIB reduces the viability of cells subjected to PERK-activation by chronic endoplasmic reticulum stress. eIF2α phosphorylation is implicated in memory consolidation. Remarkably, ISRIB-treated mice display significant enhancement in spatial and fear-associated learning. Thus, memory consolidation is inherently limited by the ISR, and ISRIB releases this brake. As such, ISRIB promises to contribute to our understanding and treatment of cognitive disorders. DOI:http://dx.doi.org/10.7554/eLife.00498.001.


Asunto(s)
Cognición , Memoria , Biosíntesis de Proteínas , ARN Mensajero/genética , Acetamidas/farmacología , Animales , Línea Celular , Ciclohexilaminas/farmacología , Retículo Endoplásmico/metabolismo , Factor 1 Eucariótico de Iniciación/antagonistas & inhibidores , Factor 1 Eucariótico de Iniciación/metabolismo , Humanos , Ratones , Fosforilación , Inhibidores de Proteínas Quinasas/farmacología
4.
J Virol ; 85(17): 8477-94, 2011 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-21697493

RESUMEN

We previously reported that the oncoproteins E6 and E7 from cutaneous human papillomavirus type 38 (HPV38) can immortalize primary human keratinocytes in vitro and sensitize transgenic mice to develop skin cancer in vivo. Immunofluorescence staining revealed that human keratinocytes immortalized by HPV38 E6 and E7 display fewer actin stress fibers than do control primary keratinocyte cells, raising the possibility of a role of the viral oncoproteins in the remodeling of the actin cytoskeleton. In this study, we show that HPV38 E7 induces actin stress fiber disruption and that this phenomenon correlates with its ability to downregulate Rho activity. The downregulation of Rho activity by HPV38 E7 is mediated through the activation of the CK2-MEK-extracellular signal-regulated kinase (ERK) pathway. In addition, HPV38 E7 is able to induce actin fiber disruption by binding directly to eukaryotic elongation factor 1A (eEF1A) and abolishing its effects on actin fiber formation. Finally, we found that the downregulation of Rho activity by HPV38 E7 through the CK2-MEK-ERK pathway facilitates cell growth proliferation. Taken together, our data support the conclusion that HPV38 E7 promotes keratinocyte proliferation in part by negatively regulating actin cytoskeleton fiber formation through the CK2-MEK-ERK-Rho pathway and by binding to eEF1A and inhibiting its effects on actin cytoskeleton remodeling.


Asunto(s)
Actinas/metabolismo , Quinasa de la Caseína II/metabolismo , Citoesqueleto/metabolismo , Factor 1 Eucariótico de Iniciación/antagonistas & inhibidores , Queratinocitos/virología , Proteínas Oncogénicas Virales/metabolismo , Papillomaviridae/patogenicidad , Línea Celular , Proliferación Celular , Humanos , Unión Proteica
5.
PLoS Pathog ; 6(11): e1001175, 2010 Nov 04.
Artículo en Inglés | MEDLINE | ID: mdl-21079685

RESUMEN

Replication of plus-strand RNA viruses depends on host factors that are recruited into viral replicase complexes. Previous studies showed that eukaryotic translation elongation factor (eEF1A) is one of the resident host proteins in the highly purified tombusvirus replicase complex. Using a random library of eEF1A mutants, we identified one mutant that decreased and three mutants that increased Tomato bushy stunt virus (TBSV) replication in a yeast model host. Additional in vitro assays with whole cell extracts prepared from yeast strains expressing the eEF1A mutants demonstrated several functions for eEF1A in TBSV replication: facilitating the recruitment of the viral RNA template into the replicase complex; the assembly of the viral replicase complex; and enhancement of the minus-strand synthesis by promoting the initiation step. These roles for eEF1A are separate from its canonical role in host and viral protein translation, emphasizing critical functions for this abundant cellular protein during TBSV replication.


Asunto(s)
Factor 1 Eucariótico de Iniciación/metabolismo , ARN Viral/biosíntesis , ARN Polimerasa Dependiente del ARN/metabolismo , Saccharomyces cerevisiae/virología , Tombusvirus/patogenicidad , Replicación Viral , Ensayo de Cambio de Movilidad Electroforética , Factor 1 Eucariótico de Iniciación/antagonistas & inhibidores , Factor 1 Eucariótico de Iniciación/genética , Mutagénesis , Mutación/genética , Conformación Proteica , ARN Viral/química , Saccharomyces cerevisiae/enzimología , Saccharomyces cerevisiae/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...